首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   30982篇
  免费   2317篇
  国内免费   370篇
耳鼻咽喉   252篇
儿科学   942篇
妇产科学   706篇
基础医学   4233篇
口腔科学   676篇
临床医学   3231篇
内科学   5916篇
皮肤病学   632篇
神经病学   2778篇
特种医学   1084篇
外国民族医学   1篇
外科学   3405篇
综合类   1230篇
现状与发展   1篇
一般理论   21篇
预防医学   3063篇
眼科学   526篇
药学   2466篇
  6篇
中国医学   345篇
肿瘤学   2155篇
  2023年   302篇
  2022年   497篇
  2021年   1052篇
  2020年   712篇
  2019年   1017篇
  2018年   1073篇
  2017年   851篇
  2016年   855篇
  2015年   1033篇
  2014年   1255篇
  2013年   1566篇
  2012年   2407篇
  2011年   2403篇
  2010年   1350篇
  2009年   1213篇
  2008年   1831篇
  2007年   1858篇
  2006年   1647篇
  2005年   1676篇
  2004年   1618篇
  2003年   1507篇
  2002年   1470篇
  2001年   681篇
  2000年   470篇
  1999年   404篇
  1998年   233篇
  1997年   222篇
  1996年   141篇
  1995年   140篇
  1994年   136篇
  1993年   109篇
  1992年   176篇
  1991年   156篇
  1990年   139篇
  1989年   121篇
  1988年   120篇
  1987年   131篇
  1986年   103篇
  1985年   105篇
  1984年   67篇
  1983年   46篇
  1982年   56篇
  1981年   38篇
  1979年   61篇
  1978年   47篇
  1975年   53篇
  1974年   66篇
  1973年   48篇
  1972年   43篇
  1971年   44篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
31.
32.
33.
马来酸罗格列酮胃漂浮型缓释片的研究   总被引:10,自引:0,他引:10       下载免费PDF全文
目的:根据流体动力学平衡控释原理(HBS)研制了马来酸罗列酮胃漂浮型缓释片。方法;以体外释放度和漂浮情况为筛选指标,采用单因素考察和正交试验设计相结合, 对胃漂浮缓释片的处方、制备工艺及体外释放条件进行优化筛选;采用γ闪烁照相技术对优化处方的内漂浮情况进行胃内动态观察。结果:马来酸罗格列酮胃漂浮缓释片在释放介质中迅速起漂,持漂时间超过12h,12h达最大累积释放;初步确定在胃内滞留时间达3h以上。结论:优化处方的释放过程符合Higuchi方程,释放机制为异常扩散;胃漂浮片在胃滞时间明显长于普通片。  相似文献   
34.
目的为抑制脑血栓形成,合成与TF基因启动子区切应力反应元件(SSRE)形成三链DNA的硫代磷酸酯寡核苷酸(TFO)。方法设计TFO序列14条,采用固相亚磷酰胺三酯固相法合成TFO。硫代磷酸酯修饰在TFO的3'末端进行。应用电泳迁移分析(EMSA)观察寡核苷酸和硫代脱氧寡核苷酸的亲和性。结果在设计合成的14条寡核苷酸中,与靶序列能形成三链DNA的TFO只有T21GTa、T14GTa和T15GTa,其Kd值分别为3.6×10-10、1.0×10-9和1.0×10-8(M),经硫代磷酸酯修饰后分别为:2.3×10-9、3.8×10-9和1.5×10-8。结论硫代磷酸酯修饰的T21GTa-ps、T14GTa-ps和T15GTa-ps能够与TF基因启动子SSRE的3个位点形成三链DNA。  相似文献   
35.
Female rats consistently show a pattern of differences in defensive behaviors compared to males which parallel the effects of exposure to a nonpainful threat stimulus (cat or cat odor) in the same tests and measures. These indications of greater defensiveness for females are particularly common in situations involving potential, as opposed to actual and present, threat, a factor which probably also reflects ceiling or floor effects in situations involving very intense defensiveness. In addition, pharmacological studies indicate sex differences in the effects of selective serotonin (5-HT) receptor agonists and antagonists on defensive responding. These findings indicate that sex effects must be considered in studies of the pharmacological control of defensive behaviors, and suggest that responsivity to sex effects may be an additional criterion for the suitability of animal models of anxiety.  相似文献   
36.
This study demonstrated the existence of specific binding sites for [3H]Ro 19-6327 in human platelet membranes. This compound is a novel, time-dependent inhibitor of monoamine oxidase type B (MAO-B) and is structurally closely related to [3H]Ro 16-6491. The density of the sites labelled with high affinity by [3H]Ro 19-6327 was similar to that observed in previous studies with [3H]Ro 16-6491 as ligand. Binding was reversible at 20 degrees C and showed a relatively slow dissociation (t1/2 = 220 min). The dissociation rate was markedly decreased (t1/2 = greater than 24h) at 0 degrees C. MAO-B, but not MAO-A inhibitors, effectively prevented the binding of [3H]Ro 19-6327. Like [3H]Ro 16-6491, [3H]Ro 19-6327 is recognized as a substrate by MAO-B, being eventually deaminated by the enzyme. Since the deaminated aldehyde derivative of Ro 19-6327 did not inhibit MAO-B, a still unidentified reversible adduct, formed at the MAO-B active site, might explain the high potency and selectivity of [3H]Ro 19-6327. Incubation of the radioligand-enzyme complex from platelet and brain membranes with NaBH3CN and acetic acid (to pH 4.5) caused the irreversible incorporation of the radioactivity into a single polypeptide as shown by SDS-PAGE analysis. This polypeptide had a molecular weight identical to that of the MAO-B subunit, i.e. 58,000. The presence of unlabelled MAO-B inhibitors in the incubation mixture prevented the covalent incorporation of [3H]Ro 19-6327. The irreversible MAO-B inhibitor, [3H] pargyline, labelled a protein with a molecular weight identical to the protein labelled by [3H]Ro 19-6327.(ABSTRACT TRUNCATED AT 250 WORDS)  相似文献   
37.
38.
A model of sleep phasic events such as vertex waves, K complexes, delta waves and sleep spindles is proposed. It consists of feedback loops that are driven by white noise (simulating tonic delta and sigma activity) and by isolated random impulses, simulating vertex waves or K complexes, depending on the background tonic activity. A model-based method for the detection of sleep phasic events was implemented in a personal computer. Its performance was investigated using simulated and real whole-night EEG signals. The method was able to detect K complexes and vertex waves in a reliable way in spite of their variable shapes and in the presence of a variety of background activities. The detector appears to have superior performance to those so far reported in the literature. The performance of the detector was also compared to that of an electroencephalographer using normal sleep EEG records of 8 h duration from 6 subjects. The performance was satisfactory both in terms of accuracy and reliability. The problem of detecting K complexes in stages 3 and 4 of sleep is discussed.  相似文献   
39.
This case report illustrates the magnetic resonance imaging (MRI) appearance of a typically asymptomatic renal oncocytoma as a homogeneous mass of medium signal with a stellate central region of decreased signal, representing the central scar. The MRI was correlated with computed tomography (CT), ultrasound (US), and gross pathologic appearance. The appearance of a central scar is not specific for oncocytoma and does not exclude renal cell carcinoma, as illustrated by a second case.  相似文献   
40.
We focus on the Fisher information matrix used for design evaluation and optimization in nonlinear mixed effects multiple response models. We evaluate the appropriateness of its expression computed by linearization as proposed for a single response model. Using a pharmacokinetic–pharmacodynamic (PKPD) example, we first compare the computation of the Fisher information matrix with approximation to one derived from the observed matrix on a large simulation using the stochastic approximation expectation–maximization algorithm (SAEM). The expression of the Fisher information matrix for multiple responses is also evaluated by comparison with the empirical information obtained through a replicated simulation study using the first‐order linearization estimation methods implemented in the NONMEM software (first‐order (FO), first‐order conditional estimate (FOCE)) and the SAEM algorithm in the MONOLIX software. The predicted errors given by the approximated information matrix are close to those given by the information matrix obtained without linearization using SAEM and to the empirical ones obtained with FOCE and SAEM. The simulation study also illustrates the accuracy of both FOCE and SAEM estimation algorithms when jointly modelling multiple responses and the major limitations of the FO method. This study highlights the appropriateness of the approximated Fisher information matrix for multiple responses, which is implemented in PFIM 3.0, an extension of the R function PFIM dedicated to design evaluation and optimization. It also emphasizes the use of this computing tool for designing population multiple response studies, as for instance in PKPD studies or in PK studies including the modelling of the PK of a drug and its active metabolite. Copyright © 2009 John Wiley & Sons, Ltd.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号